These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 26396117)
1. New and Emerging Treatments for Rosacea. Gold LM; Draelos ZD Am J Clin Dermatol; 2015 Dec; 16(6):457-61. PubMed ID: 26396117 [TBL] [Abstract][Full Text] [Related]
2. Microencapsulated Benzoyl Peroxide for Rosacea in Context: A Review of the Current Treatment Landscape. Desai SR; Baldwin H; Del Rosso JQ; Gallo RL; Bhatia N; Harper JC; York JP; Gold LS Drugs; 2024 Mar; 84(3):275-284. PubMed ID: 38418773 [TBL] [Abstract][Full Text] [Related]
3. Rosacea: Common Questions and Answers. Frazier W; Zemtsov RK; Ge Y Am Fam Physician; 2024 Jun; 109(6):533-542. PubMed ID: 38905551 [TBL] [Abstract][Full Text] [Related]
4. Rosacea in Older Adults and Pharmacologic Treatments. Lee JJ; Chien AL Drugs Aging; 2024 May; 41(5):407-421. PubMed ID: 38649625 [TBL] [Abstract][Full Text] [Related]
6. Rosacea and autoimmune disease: a case-control study in the all of us database. Piontkowski AJ; Mikhaylov D; Alani O; Orloff J; Powers C; Gulati N; Ungar B Arch Dermatol Res; 2024 May; 316(6):252. PubMed ID: 38795192 [No Abstract] [Full Text] [Related]
7. Facial Erythema of Rosacea - Aetiology, Different Pathophysiologies and Treatment Options. Steinhoff M; Schmelz M; Schauber J Acta Derm Venereol; 2016 Jun; 96(5):579-86. PubMed ID: 26714888 [TBL] [Abstract][Full Text] [Related]
8. What's new in acne and rosacea? Keri J Semin Cutan Med Surg; 2016 Jun; 35(2):103-6. PubMed ID: 27416316 [TBL] [Abstract][Full Text] [Related]
9. Topical and oral therapeutic approach to rosacea. Helfrich YR; Maier LM Semin Cutan Med Surg; 2016 Jun; 35(2):74-8. PubMed ID: 27416312 [TBL] [Abstract][Full Text] [Related]
10. Additional evidence that rosacea pathogenesis may involve demodex: new information from the topical efficacy of ivermectin and praziquantel. Abokwidir M; Fleischer AB Dermatol Online J; 2015 Sep; 21(9):. PubMed ID: 26437294 [TBL] [Abstract][Full Text] [Related]
11. Brimonidine gel 0.33% rapidly improves patient-reported outcomes by controlling facial erythema of rosacea: a randomized, double-blind, vehicle-controlled study. Layton AM; Schaller M; Homey B; Hofmann MA; Bewley AP; Lehmann P; Nohlgård C; Sarwer DB; Kerrouche N; Ma YM J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2405-10. PubMed ID: 26416154 [TBL] [Abstract][Full Text] [Related]
12. Rosacea Management. Abokwidir M; Feldman SR Skin Appendage Disord; 2016 Sep; 2(1-2):26-34. PubMed ID: 27843919 [TBL] [Abstract][Full Text] [Related]
14. The efficacy, safety, and tolerability of ivermectin compared with current topical treatments for the inflammatory lesions of rosacea: a network meta-analysis. Siddiqui K; Stein Gold L; Gill J Springerplus; 2016; 5(1):1151. PubMed ID: 27504249 [TBL] [Abstract][Full Text] [Related]
15. Update on the Management of Rosacea. Weinkle AP; Doktor V; Emer J Plast Surg Nurs; 2015; 35(4):184-202. PubMed ID: 26605825 [TBL] [Abstract][Full Text] [Related]
16. Deciphering the enigma of rosacea continues…. Tan JK Br J Dermatol; 2015 Sep; 173(3):637-8. PubMed ID: 26404573 [No Abstract] [Full Text] [Related]
17. The role of brimonidine tartrate gel in the treatment of rosacea. Jackson JM; Knuckles M; Minni JP; Johnson SM; Belasco KT Clin Cosmet Investig Dermatol; 2015; 8():529-38. PubMed ID: 26566370 [TBL] [Abstract][Full Text] [Related]